Category: Research & Development
Research & Development market research reports by DelveInsight
-
Molecular Modeling Market Insights, Competitive Landscape and, Market Forecast - 2027
Molecular Modeling Market Insights, Competitive Landscape and, Market Forecast - 2027 MOLECULAR MODELING MARKET BY PRODUCT TYPE (SOFTWARE AND SERVICES), BY END-USER (BIOTECH AND PHARMACEUTICAL INDUSTRIES, RESEARCH ORGANISATIONS, AND OTHERS), BY GEOGRAPHY IS ESTIMATED TO REGISTER GROWTH AT A REMARKAB ... Read More
-
RNA- Competitive Landscape, 2022
RNA- Competitive Landscape, 2022 DelveInsight’s, “RNA- Competitive landscape, 2022,” report provides comprehensive insights about 85+ companies and 100+ drugs in RNA Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It fu ... Read More
-
RNA- Competitive Landscape, 2022
RNA- Competitive Landscape, 2022 DelveInsight’s, “RNA- Competitive landscape, 2022,” report provides comprehensive insights about 85+ companies and 100+ drugs in RNA Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It fu ... Read More
-
T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2022
“ T-cell Surface Glycoprotein CD4- Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in T-cell Surface Glycoprotein CD4 pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast to 2032
DelveInsight's "" PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted PCSK9 Inhibitors (PCSK9i) disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the U ... Read More
-
Interferon - Biosimilar Insight, 2022
DelveInsight’s, “ Interferon– Biosimilar 2022 ,” report provides comprehensive insights about 10+ companies and 10+ marketed and pipeline drugs in Interferon Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More
-
Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032
DelveInsight's "" Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene and Cell Therapies targeting CNS disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spa ... Read More
-
Cytokine Release Syndrome (CRS)-Epidemiology Forecast–2032
DelveInsight's "" Cytokine Release Syndrome (CRS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Cytokine Release Syndrome (CRS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Unite ... Read More
Research Assistance
